Floatz logo

PRAVASTATIN

Progeria

Boston Children's HospitalSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Progeria cohort.

Asset / SponsorPhaseRating
Zoledronate
Boston Children's Hospital
Phase 2B
Progerinin
PRG Science & Technology Co., Ltd.
Phase 2B
Lonafarnib
PRG Science & Technology Co., Ltd.
Phase 2B

Same molecule, other indications

PRAVASTATIN is also rated in:

hyperlipidemiaDormant
BBB
Indicative ·
76 / 100
View asset →
lipodystrophyDormant
BBB
Indicative ·
76 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →